Blood Pressure, Healthy Nutrition, Hypertension, Obesity
Conditions
Brief summary
Hypertension and obesity are both major risk factors for cardiovascular disease (CVD), a leading cause of death for Black women in the United States. The investigators propose examining the feasibility and acceptability of the 12-week RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) intervention - grocery delivery, cooking classes, and nutrition education - for Black women with hypertension and obesity to improve nutritious eating habits and blood pressure control.
Detailed description
The objective of this study is to conduct the RN-CHeFRx (Real Nourishment and Cooking Healthy Food is Rx) for 12 weeks among Black women who are obese and hypertensive living Chicago. We propose to 1) Pilot the RN-CHEFRx intervention and measures that will be used to assess blood pressure, BMI status, and sodium intake with 20 Black women diagnosed with hypertension and BMI ≥ 30. We will assess the efficacy of the evaluation tools to be used in a future clinical trial at three-time points (baseline, 12 weeks, and 6 months); and 2) Assess the feasibility and acceptability of the RN-CHeFRx intervention using interviews, surveys, and documentary analysis. Findings from this study will inform a larger efficacy trial of RN-CHeFRx to improve dietary behaviors and blood pressure control among Black women with hypertension and obesity.
Interventions
The RN-CHeFRx trial to enhance dietary intake and blood pressure control in Black women with hypertension and obesity compared to usual care.
Sponsors
Study design
Eligibility
Inclusion criteria
* self-identified as Black or of African descent * female * ≥ 18 years old * baseline blood pressure ≥130/85 or diagnosed with hypertension and BMI ≥ 30
Exclusion criteria
* inability to cook in their homes * cognitive deficits impeding the ability to participate or provide informed consent * current treatment for cancer * liver or renal disease * pregnancy * lack of English language proficiency
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of participants who complete the 12 week intervention | Up to 12 weeks | Completion will be measured by class attendance |
| Number of participants recruited | Up to 12 weeks | Patients recruited, screened, eligible and consented to participate in the study |
| Number of participants who complete data collection visits | Baseline to 4 months | Completion measured by participants completing surveys, blood pressure measurements, and those who provide blood biospecimens |
| Acceptability of the intervention | Up to 12 weeks | Assessed via participant feedback |
| Change in mean blood pressures (mmHg) during intervention | Baseline to 12 weeks | Change will be measured by comparing blood pressures from baseline to 12 weeks |
| dietary intake during intervention | Baseline to 12 weeks | Dietary intake at baseline and 12 weeks |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in body weight during intervention | Up to 12 weeks | Change will be measured by comparing body weight obtained at baseline and 12 weeks |
| Change in body weight at 6 months | 12 weeks to 24 weeks | Change will be measured by comparing body weight (kg) obtained at 12 weeks and at 24 weeks. |
| Change in blood pressure at 6 months | 12 weeks to 24 weeks | Change will be measured by comparing systolic and diastolic blood pressure at 12 weeks to 24 weeks |
| Dietary intake during post-intervention | 12 weeks to 24 weeks | Dietary intake from 12 weeks to 24 weeks |
Countries
United States